Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 652

1.

Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.

Faridi KF, Quispe R, Martin SS, Hendrani AD, Joshi PH, Brinton EA, Cruz DE, Banach M, Toth PP, Kulkarni K, Jones SR.

J Clin Lipidol. 2019 Jun 11. pii: S1933-2874(19)30213-2. doi: 10.1016/j.jacl.2019.06.001. [Epub ahead of print]

PMID:
31320236
2.

The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.

Dyrbuś K, Gąsior M, Desperak P, Osadnik T, Nowak J, Banach M.

Atherosclerosis. 2019 Jun 15;288:33-41. doi: 10.1016/j.atherosclerosis.2019.06.899. [Epub ahead of print]

PMID:
31319356
3.

Possible Mechanism of Amyloidogenesis of V Domains.

Banach M, Kalinowska B, Konieczny L, Roterman I.

In: Roterman I, Konieczny L, editors. Self-Assembled Molecules – New Kind of Protein Ligands: Supramolecular Ligands [Internet]. Cham (CH): Springer; 2018. Chapter 5.
2017 Nov 4.

4.

Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease.

Mazidi M, Katsiki N, Mikhailidis DP, Banach M.

J Am Coll Nutr. 2019 Jul 15:1-7. doi: 10.1080/07315724.2018.1507011. [Epub ahead of print]

PMID:
31305223
5.

Structural analysis of the Aβ(11-42) amyloid fibril based on hydrophobicity distribution.

Roterman I, Dułak D, Gadzała M, Banach M, Konieczny L.

J Comput Aided Mol Des. 2019 Jul 10. doi: 10.1007/s10822-019-00209-9. [Epub ahead of print]

PMID:
31292794
6.

Dietary Choline is Positively Related to Overall and Cause-Specific Mortality: Results from Individuals of the National Health and Nutrition Examination Survey and Pooling Prospective Data.

Mazidi M, Katsiki N, Mikhailidis DP, Banach M.

Br J Nutr. 2019 Jul 10:1-22. doi: 10.1017/S0007114519001065. [Epub ahead of print]

PMID:
31288869
7.

The potential role of inflammation in cryptogenic stroke.

Gąsiorek P, Banach M, Sakowicz A, Głąbiński A, Sosnowska B, Maciejewski M, Bielecka-Dabrowa A.

Adv Med Sci. 2019 Jun 28;64(2):381-387. doi: 10.1016/j.advms.2019.06.001. [Epub ahead of print]

PMID:
31260841
8.

PCSK9 and inflammation: a review of experimental and clinical evidence.

Momtazi-Borojeni AA, Sabouri-Rad S, Gotto AM, Pirro M, Banach M, Awan Z, Barreto GE, Sahebkar A.

Eur Heart J Cardiovasc Pharmacother. 2019 Jun 25. pii: pvz022. doi: 10.1093/ehjcvp/pvz022. [Epub ahead of print]

PMID:
31236571
9.

Evolutionary Underpinnings of Innate-Like T Cell Interactions with Cancer.

Banach M, Robert J.

Immunol Invest. 2019 Jun 21:1-22. doi: 10.1080/08820139.2019.1631341. [Epub ahead of print]

PMID:
31223047
10.

The Effect of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Hereditary Spastic Paraplegia.

Antczak J, Pera J, Dąbroś M, Koźmiński W, Czyżycki M, Wężyk K, Dwojak M, Banach M, Slowik A.

Neural Plast. 2019 May 12;2019:7638675. doi: 10.1155/2019/7638675. eCollection 2019.

11.

Methotrexate for Cardiovascular Risk Reduction: The Right Choice?

Reiner Ž, Sirtori CR, Banach M, Ruscica M, Sahebkar A.

Angiology. 2019 Jun 11:3319719855165. doi: 10.1177/0003319719855165. [Epub ahead of print] No abstract available.

PMID:
31185727
12.

Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Mazidi M, Katsiki N, Mikhailidis DP, Pencina MJ, Banach M.

J Am Coll Nutr. 2019 Jun 7:1-12. doi: 10.1080/07315724.2018.1534620. [Epub ahead of print]

PMID:
31173548
13.

Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy.

Busuioc RM, Covic A, Kanbay M, Banach M, Burlacu A, Mircescu G.

Nephrol Dial Transplant. 2019 Jun 3. pii: gfz108. doi: 10.1093/ndt/gfz108. [Epub ahead of print]

PMID:
31157893
14.

Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus.

Banach M, Edholm ES, Gonzalez X, Benraiss A, Robert J.

Carcinogenesis. 2019 Jul 20;40(7):924-935. doi: 10.1093/carcin/bgz100.

PMID:
31155639
15.

Effects of immunization against PCSK9 in an experimental model of breast cancer.

Momtazi-Borojeni AA, Nik ME, Jaafari MR, Banach M, Sahebkar A.

Arch Med Sci. 2019 May;15(3):570-579. doi: 10.5114/aoms.2019.84734. Epub 2019 Apr 30.

16.

Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.

Momtazi-Borojeni AA, Nik ME, Jaafari MR, Banach M, Sahebkar A.

Arch Med Sci. 2019 May;15(3):559-569. doi: 10.5114/aoms.2019.84732. Epub 2019 Apr 30.

17.

Statins: Then and Now.

Toth PP, Banach M.

Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):23-31. doi: 10.14797/mdcj-15-1-23. Review.

18.

Do we know more about hypertension in Poland after the May Measurement Month 2017?-Europe.

Małyszko J, Mastej M, Banach M, Tykarski A, Narkiewicz K, Hoffman P, Jankowski P, Nowicki MP, Tomasik T, Windak A, Olszanecka A, Motyl A, Nowak D, Skowron Ł, Tomaszewski M, Beaney T, Xia X, Nillson P, Poulter NR, Jóźwiak J.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D97-D100. doi: 10.1093/eurheartj/suz067. Epub 2019 Apr 24.

19.

Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies.

Mazidi M, Katsiki N, Mikhailidis DP, Sattar N, Banach M.

Eur Heart J. 2019 Apr 19. pii: ehz174. doi: 10.1093/eurheartj/ehz174. [Epub ahead of print]

PMID:
31004146
20.

Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.

Simental-Mendía LE, Simental-Mendía M, Sánchez-García A, Banach M, Serban MC, Cicero AFG, Sahebkar A.

Lipids Health Dis. 2019 Apr 6;18(1):88. doi: 10.1186/s12944-019-1041-4. Review.

21.

Secondary and Supersecondary Structure of Proteins in Light of the Structure of Hydrophobic Cores.

Banach M, Konieczny L, Roterman I.

Methods Mol Biol. 2019;1958:347-378. doi: 10.1007/978-1-4939-9161-7_19.

PMID:
30945229
22.

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.

Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG.

J Am Heart Assoc. 2019 Apr 2;8(7):e011662. doi: 10.1161/JAHA.118.011662.

23.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

24.

A review of gene- and cell-based therapies for familial hypercholesterolemia.

Hajighasemi S, Mahdavi Gorabi A, Bianconi V, Pirro M, Banach M, Ahmadi Tafti H, Reiner Ž, Sahebkar A.

Pharmacol Res. 2019 May;143:119-132. doi: 10.1016/j.phrs.2019.03.016. Epub 2019 Mar 22. Review.

PMID:
30910740
25.

Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis.

Kotlęga D, Gołąb-Janowska M, Meller A, Bajer-Czajkowska A, Zembroń-Łacny A, Nowacki P, Banach M.

Arch Med Sci. 2019 Mar;15(2):385-392. doi: 10.5114/aoms.2019.82925. Epub 2019 Mar 4.

26.

Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey.

Mazidi M, Katsiki N, Mikhailidis DP, Banach M.

Atherosclerosis. 2019 May;284:129-135. doi: 10.1016/j.atherosclerosis.2018.11.012. Epub 2018 Nov 8.

PMID:
30878840
27.

Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: A population-based survey.

Mazidi M, Katsiki N, Mikhailidis DP, Banach M.

Atherosclerosis. 2019 May;284:44-49. doi: 10.1016/j.atherosclerosis.2018.09.016. Epub 2018 Sep 15.

PMID:
30875492
28.

Conference report: The 14th congress of the International Society of Developmental and Comparative Immunology.

Abernath K, Banach M, Barela Hudgell MA, Blackmon LE, Breaux B, Brusch GA 4th, Criscitiello MF, Deiss TC, Ding Y, Flowers E, Kenney E, Matz H, Modak T, Ott J, Rhoo KH, Rusnak ED, Shibasaki Y, Tassia MG, Wcisel D, Yaparla A.

Dev Comp Immunol. 2019 Jul;96:83-92. doi: 10.1016/j.dci.2019.02.016. Epub 2019 Mar 7. No abstract available.

PMID:
30851292
29.

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials.

Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP).

Pharmacol Res. 2019 May;143:1-16. doi: 10.1016/j.phrs.2019.02.028. Epub 2019 Mar 4. Review.

PMID:
30844537
30.

Novel therapeutic strategies for stroke: The role of autophagy.

Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S.

Crit Rev Clin Lab Sci. 2019 May;56(3):182-199. doi: 10.1080/10408363.2019.1575333. Epub 2019 Mar 1.

PMID:
30821184
31.

ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials.

Ruscica M, Banach M, Sahebkar A, Corsini A, Sirtori CR.

Expert Opin Pharmacother. 2019 May;20(7):791-803. doi: 10.1080/14656566.2019.1583209. Epub 2019 Feb 27.

PMID:
30810432
32.

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.

Sahebkar A, Simental-Mendía LE, Katsiki N, Reiner Ž, Banach M, Pirro M, Atkin SL.

BMJ Open. 2019 Feb 22;8(11):e021508. doi: 10.1136/bmjopen-2018-021508.

33.

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels - experimental and clinical approaches with lipid-lowering agents.

Macchi C, Banach M, Corsini A, Sirtori CR, Ferri N, Ruscica M.

Eur J Prev Cardiol. 2019 Jun;26(9):930-949. doi: 10.1177/2047487319831500. Epub 2019 Feb 18.

34.

Antitumor effects of curcumin: A lipid perspective.

Naeini MB, Momtazi AA, Jaafari MR, Johnston TP, Barreto G, Banach M, Sahebkar A.

J Cell Physiol. 2019 Feb 11. doi: 10.1002/jcp.28262. [Epub ahead of print] Review.

PMID:
30741424
35.

A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations.

Ursoniu S, Sahebkar A, Serban MC, Pinzaru I, Dehelean C, Noveanu L, Rysz J, Banach M; Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group.

Arch Med Sci. 2019 Jan;15(1):12-22. doi: 10.5114/aoms.2018.81034. Epub 2018 Dec 30. Review.

36.

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies.

Pirro M, Simental-Mendía LE, Bianconi V, Watts GF, Banach M, Sahebkar A.

J Clin Med. 2019 Jan 18;8(1). pii: E118. doi: 10.3390/jcm8010118. Review.

37.

Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent.

Mohammadi A, Blesso CN, Barreto GE, Banach M, Majeed M, Sahebkar A.

J Nutr Biochem. 2019 Apr;66:1-16. doi: 10.1016/j.jnutbio.2018.12.005. Epub 2018 Dec 21. Review.

PMID:
30660832
38.

Dietary natural products as emerging lipoprotein(a)-lowering agents.

Momtazi-Borojeni AA, Katsiki N, Pirro M, Banach M, Rasadi KA, Sahebkar A.

J Cell Physiol. 2019 Aug;234(8):12581-12594. doi: 10.1002/jcp.28134. Epub 2019 Jan 13. Review.

PMID:
30637725
39.

A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study.

Mazidi M, Katsiki N, Banach M.

J Nutr Biochem. 2019 Mar;65:66-71. doi: 10.1016/j.jnutbio.2018.10.001. Epub 2018 Oct 11.

PMID:
30623852
40.

Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth.

Grzesiak M, Gaj Z, Kocyłowski R, Suliburska J, Oszukowski P, Horzelski W, von Kaisenberg C, Banach M.

Oxid Med Cell Longev. 2018 Dec 2;2018:3919106. doi: 10.1155/2018/3919106. eCollection 2018.

41.

Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.

Jenkins DJA, Kendall CWC, Lamarche B, Banach MS, Srichaikul K, Vidgen E, Mitchell S, Parker T, Nishi S, Bashyam B, de Souza RJ, Ireland C, Pichika SC, Beyene J, Sievenpiper JL, Josse RG.

Diabetologia. 2019 Mar;62(3):549-552. doi: 10.1007/s00125-018-4795-8.

PMID:
30617725
42.

The Polish version of the Boston Carpal Tunnel Questionnaire: Associations between patient-rated outcome measures and nerve conduction studies.

Trybus M, Koziej M, Belka M, Bednarek M, Banach M.

J Plast Reconstr Aesthet Surg. 2019 Jun;72(6):924-932. doi: 10.1016/j.bjps.2018.12.032. Epub 2018 Dec 14.

PMID:
30611680
43.

What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?

Banach M, Penson PE.

Cardiovasc Res. 2019 Mar 1;115(3):e26-e31. doi: 10.1093/cvr/cvy301. No abstract available.

PMID:
30605511
44.

Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis.

Mazidi M, Mikhailidis DP, Sattar N, Howard G, Graham I, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Clin Nutr. 2018 Dec 18. pii: S0261-5614(18)32583-4. doi: 10.1016/j.clnu.2018.12.015. [Epub ahead of print]

PMID:
30595374
45.

The aqueous environment as an active participant in the protein folding process.

Gadzała M, Dułak D, Kalinowska B, Baster Z, Bryliński M, Konieczny L, Banach M, Roterman I.

J Mol Graph Model. 2019 Mar;87:227-239. doi: 10.1016/j.jmgm.2018.12.008. Epub 2018 Dec 14.

46.

Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.

Penson P, Long DL, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M.

Cardiovasc Res. 2019 Jan 1;115(1):204-212. doi: 10.1093/cvr/cvy198.

PMID:
30576432
47.

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, Asayesh H, Asgedom SW, Atey TM, Ayele HT, Banach M, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Barregard L, Basu S, Bedi N, Behzadifar M, Béjot Y, Bennett DA, Bensenor IM, Berhe DF, Boneya DJ, Brainin M, Campos-Nonato IR, Caso V, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Christensen H, Criqui MH, Damasceno A, Dandona L, Dandona R, Davletov K, de Courten B, deVeber G, Dokova K, Edessa D, Endres M, Faraon EJA, Farvid MS, Fischer F, Foreman K, Forouzanfar MH, Gall SL, Gebrehiwot TT, Geleijnse JM, Gillum RF, Giroud M, Goulart AC, Gupta R, Gupta R, Hachinski V, Hamadeh RR, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Hegazy MI, Hibstu DT, James SL, Jeemon P, John D, Jonas JB, Jóźwiak J, Kalani R, Kandel A, Kasaeian A, Kengne AP, Khader YS, Khan AR, Khang YH, Khubchandani J, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kolte D, Kopec JA, Kosen S, Kravchenko M, Krishnamurthi R, Kumar GA, Lafranconi A, Lavados PM, Legesse Y, Li Y, Liang X, Lo WD, Lorkowski S, Lotufo PA, Loy CT, Mackay MT, Abd El Razek HM, Mahdavi M, Majeed A, Malekzadeh R, Malta DC, Mamun AA, Mantovani LG, Martins SCO, Mate KK, Mazidi M, Mehata S, Meier T, Melaku YA, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Miazgowski T, Miller TR, Ibrahim NM, Mohammed S, Mokdad AH, Moosazadeh M, Moran AE, Musa KI, Negoi RI, Nguyen M, Nguyen QL, Nguyen TH, Tran TT, Nguyen TT, Anggraini Ningrum DN, Norrving B, Noubiap JJ, O’Donnell MJ, Olagunju AT, Onuma OK, Owolabi MO, Parsaeian M, Patton GC, Piradov M, Pletcher MA, Pourmalek F, Prakash V, Qorbani M, Rahman M, Rahman MA, Rai RK, Ranta A, Rawaf D, Rawaf S, Renzaho AM, Robinson SR, Sahathevan R, Sahebkar A, Salomon JA, Santalucia P, Santos IS, Sartorius B, Schutte AE, Sepanlou SG, Shafieesabet A, Shaikh MA, Shamsizadeh M, Sheth KN, Sisay M, Shin MJ, Shiue I, Silva DAS, Sobngwi E, Soljak M, Sorensen RJD, Sposato LA, Stranges S, Suliankatchi RA, Tabarés-Seisdedos R, Tanne D, Nguyen CT, Thakur JS, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Nguyen LT, Truelsen T, Tsilimparis N, Tyrovolas S, Ukwaja KN, Uthman OA, Varakin Y, Vasankari T, Venketasubramanian N, Vlassov VV, Wang W, Werdecker A, Wolfe CDA, Xu G, Yano Y, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zhou M, Ziaeian B, Zipkin B, Vos T, Naghavi M, Murray CJL, Roth GA.

N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.

48.

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Simental-Mendía LE, Pirro M, Banach M, Watts GF, Sirotri C, Al-Rasadi K, Atkin SL.

Sci Rep. 2018 Dec 14;8(1):17887. doi: 10.1038/s41598-018-36204-7.

49.

Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes - Data from the TERCET registry with 19,287 patients.

Dyrbus K, Gasior M, Desperak P, Nowak J, Osadnik T, Banach M.

Pharmacol Res. 2019 Jan;139:460-466. doi: 10.1016/j.phrs.2018.12.002. Epub 2018 Dec 6.

PMID:
30527895
50.

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF).

Lip GYH, Merino JL, Banach M, de Groot JR, Maier LS, Themistoclakis S, Boriani G, Jin J, Melino M, Winters SM, Goette A.

Am J Cardiol. 2019 Feb 15;123(4):592-597. doi: 10.1016/j.amjcard.2018.11.019. Epub 2018 Nov 24.

PMID:
30527775

Supplemental Content

Loading ...
Support Center